PRK1- COMPARISON OF DIRECT HEALTH-CARE COST, HOSPITAL UTILIZATION AND MEDICATION PERSISTENCE BETWEEN EXTENDED RELEASE FORMS (ER) OF TOLTERODINE AND OXYBUTYNIN IN OVERACTIVE BLADDER/URINARY INCONTINENCE PATIENTS
May 1, 2003, 00:00
10.1016/S1098-3015(10)64064-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)64064-8/fulltext
Title :
PRK1- COMPARISON OF DIRECT HEALTH-CARE COST, HOSPITAL UTILIZATION AND MEDICATION PERSISTENCE BETWEEN EXTENDED RELEASE FORMS (ER) OF TOLTERODINE AND OXYBUTYNIN IN OVERACTIVE BLADDER/URINARY INCONTINENCE PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64064-8&doi=10.1016/S1098-3015(10)64064-8
First page :
Section Title :
Open access? :
No
Section Order :
265